Cocrystal Pharma Statistics
Total Valuation
COCP has a market cap or net worth of $20.81 million. The enterprise value is $15.29 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, before market open.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
COCP has 13.78 million shares outstanding. The number of shares has increased by 10.97% in one year.
| Current Share Class | 13.78M |
| Shares Outstanding | 13.78M |
| Shares Change (YoY) | +10.97% |
| Shares Change (QoQ) | +25.68% |
| Owned by Insiders (%) | 33.83% |
| Owned by Institutions (%) | 5.70% |
| Float | 9.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.29 |
| P/TBV Ratio | 3.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.68, with a Debt / Equity ratio of 0.24.
| Current Ratio | 3.68 |
| Quick Ratio | 3.50 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -111.40% and return on invested capital (ROIC) is -58.82%.
| Return on Equity (ROE) | -111.40% |
| Return on Assets (ROA) | -48.66% |
| Return on Invested Capital (ROIC) | -58.82% |
| Return on Capital Employed (ROCE) | -120.22% |
| Weighted Average Cost of Capital (WACC) | 10.03% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$802,818 |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.34% in the last 52 weeks. The beta is 1.18, so COCP's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | +6.34% |
| 50-Day Moving Average | 1.03 |
| 200-Day Moving Average | 1.23 |
| Relative Strength Index (RSI) | 78.72 |
| Average Volume (20 Days) | 6,822,461 |
Short Selling Information
The latest short interest is 214,196, so 1.55% of the outstanding shares have been sold short.
| Short Interest | 214,196 |
| Short Previous Month | 263,840 |
| Short % of Shares Out | 1.55% |
| Short % of Float | 2.35% |
| Short Ratio (days to cover) | 5.41 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.02M |
| Pretax Income | -8.83M |
| Net Income | -8.83M |
| EBITDA | -8.95M |
| EBIT | -9.02M |
| Earnings Per Share (EPS) | -$0.78 |
Full Income Statement Balance Sheet
The company has $7.03 million in cash and $1.51 million in debt, with a net cash position of $5.52 million or $0.40 per share.
| Cash & Cash Equivalents | 7.03M |
| Total Debt | 1.51M |
| Net Cash | 5.52M |
| Net Cash Per Share | $0.40 |
| Equity (Book Value) | 6.33M |
| Book Value Per Share | 0.46 |
| Working Capital | 5.92M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$8.19 million and capital expenditures -$12,000, giving a free cash flow of -$8.20 million.
| Operating Cash Flow | -8.19M |
| Capital Expenditures | -12,000 |
| Depreciation & Amortization | 72,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -8.20M |
| FCF Per Share | -$0.60 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
COCP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.97% |
| Shareholder Yield | -10.97% |
| Earnings Yield | -42.43% |
| FCF Yield | -39.42% |
Analyst Forecast
The average price target for COCP is $6.00, which is 297.35% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.00 |
| Price Target Difference | 297.35% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 11, 2022. It was a reverse split with a ratio of 1:12.
| Last Split Date | Oct 11, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |